DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening
DIASENTINEL combines deterministic extraction, guideline retrieval, risk prediction, and hybrid verification on-premise. It is a useful architecture reference for auditable agents handling sensitive data.
DIASENTINEL is an **on-premise multi-agent system** for one-year diabetes-risk screening from EHRs. It combines calibrated prediction, deterministic signal extraction, **Reciprocal Rank Fusion** over ADA guidelines, and rule-plus-LLM verification.
For high-stakes agent workflows, separate extraction, retrieval, generation, and verification instead of asking one model to do everything. Preserve cited recommendations, verification outcomes, and raw-input comparisons for review.
DIASENTINEL is an **on-premise multi-agent system** for one-year diabetes-risk screening from EHRs. It combines calibrated prediction, deterministic signal extraction, **Reciprocal Rank Fusion** over ADA guidelines, and rule-plus-LLM verification. For high-stakes agent workflows, separate extraction, retrieval, generation, and verification instead of asking one model to do everything. Preserve cited recommendations, verification outcomes, and raw-input comparisons for review. The material describes a demonstration but gives no accuracy, calibration, hallucination, or operational benchmarks. Its reliability and clinical usefulness therefore cannot be judged from the abstract alone.
This confirms the prior pattern that high-stakes agents need staged responsibilities, deterministic controls, provenance, and reviewable verification rather than a single fluent pass. It applies that architecture to on-premise clinical screening and adds raw-input comparison, but narrows confidence sharply: unlike candidates with measured task results, the abstract supplies no evidence that the design improves prediction, calibration, or clinical reliability.